
11 - 50 employees
Founded 2018
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
Savara is a clinical-stage biopharmaceutical company focused on developing treatments for rare respiratory diseases, principally autoimmune pulmonary alveolar proteinosis (aPAP). Their lead product candidate, MOLBREEVI (molgramostim inhalation solution), is an inhaled recombinant GM-CSF currently in Phase 3 development for aPAP; the company maintains clinical programs, medical affairs, patient resources, and investor relations activities related to advancing this therapy. Savara conducts clinical trials, engages with investigators and patient advocacy organizations, and provides information on diagnostics, expanded access, and regulatory status.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 3 days ago
Clinical QA consultant overseeing GCP compliance, vendors, audits, and quality events for Savara’s Early Access Program. Supporting transition to commercial product pending Health Authority approval.
🔔 Pennsylvania – Remote
⏳ Contract/Temporary
🟡 Mid-level
🟠 Senior
🔧 QA Engineer (Quality Assurance)
👻 Ghost score 15%
🕒 August 26
Senior Product Manager advancing Savara’s investigational MOLBREEVI therapy for rare respiratory disease. Developing US brand strategy, launch programs, and HCP and patient marketing initiatives.